Hoffmann-La Roche: all 2,744 studies
Page 27 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal ImpairmentCompletedNCT00144573Not applicable
- Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)CompletedNCT00144560Not applicable
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JPCompletedNCT00144547Phase 3
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JPCompletedNCT00144534Phase 3
- Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)CompletedNCT00144521Phase 3
- Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)CompletedNCT00144508Phase 3
- A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing ChemotherapyCompletedNCT00144495Phase 3
- A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing ChemotherapyCompletedNCT00144482Phase 3
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis CCompletedNCT00144469Phase 3
- A New Active Vitamin D, ED-71 for OsteoporosisCompletedNCT00144456Phase 3
- Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant RecipientsTerminatedNCT00121784Phase 4
- A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal CancerTerminatedNCT00114946Phase 4
- A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesCompletedNCT00111670Phase 2
- A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial PneumoniaCompletedNCT00111644Phase 2
- A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesCompletedNCT00111631Phase 2
- A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid ArthritisCompletedNCT00109408Phase 3
- A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic TherapyCompletedNCT00109317Phase 3
- A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following ChemotherapyCompletedNCT00109265Phase 2
- A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390gCompletedNCT00109252Phase 3
- A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast CancerCompletedNCT00109239Phase 3
- A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT00109226Phase 2
- A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic AsthmaCompletedNCT00109200Phase 3
- An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143gCompletedNCT00109187Phase 3
- A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal CancerCompletedNCT00109070Phase 3
- An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer StudyCompletedNCT00109057Phase 2
- A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106574Phase 3
- A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106548Phase 3
- A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate TherapyCompletedNCT00106522Phase 3
- A Study of Patients With HER2-Positive Metastatic Breast CancerCompletedNCT00105456
- A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.WithdrawnNCT00104143Phase 2
- A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1TerminatedNCT00100984Phase 4
- A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone DiseaseTerminatedNCT00099203Phase 3
- A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe PainTerminatedNCT00099177Phase 3
- A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)CompletedNCT00097617
- A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal AdenocarcinomaCompletedNCT00097578
- An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's LymphomaCompletedNCT00097565
- A Study to Evaluate Subjects With Turner Syndrome Treated With Growth HormoneCompletedNCT00097552
- Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)CompletedNCT00097526
- National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) PatientsCompletedNCT00097513
- A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a TaxaneCompletedNCT00097487
- An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)CompletedNCT00097240
- A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple SclerosisCompletedNCT00097188Phase 2
- A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has FailedCompletedNCT00097019Phase 2
- A Study to Evaluate Raptiva in Combination With Topical Psoriasis TherapiesCompletedNCT00096980Phase 4
- A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer StudyCompletedNCT00096967Phase 3
- A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)CompletedNCT00096928
- A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600gCompletedNCT00096603Phase 3
- Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)CompletedNCT00095433Phase 3
- A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)CompletedNCT00095225Phase 2
- A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00091663Phase 3
- A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00090623Phase 3
- A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected PatientsCompletedNCT00089492Phase 2
- A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast CancerTerminatedNCT00087620Phase 4
- Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney TransplantationCompletedNCT00087581Phase 4
- A Safety and Efficacy Study of Xolair in Peanut AllergyTerminatedNCT00086606Phase 2
- CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)CompletedNCT00084279Phase 2
- A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell CarcinomaCompletedNCT00081614Phase 2
- A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNCT00081484Phase 3
- A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on DialysisCompletedNCT00081471Phase 3
- A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic FibrosisCompletedNCT00079742Phase 2
- A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid ArthritisCompletedNCT00077870Phase 1/2
- A Study of Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNCT00077597Phase 3
- An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPFTerminatedNCT00076635Phase 3
- The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT00075998Phase 3
- Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid ArthritisCompletedNCT00074438Phase 2
- A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot UlcersCompletedNCT00069446Phase 1
- A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular DegenerationCompletedNCT00061594Phase 3
- Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell CarcinomaWithdrawnNCT00061178Phase 3
- Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone MetastasesCompletedNCT00060138Phase 1/2
- Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma PatientsTerminatedNCT00057447Phase 1/2
- Study of Ro 205-2349 in Patients With Type 2 Diabetes MellitusCompletedNCT00057317Phase 2
- Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes MellitusCompletedNCT00057304Phase 2
- A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular DegenerationCompletedNCT00056836Phase 3
- Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)CompletedNCT00056823Phase 1/2
- A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.CompletedNCT00055510Phase 2/3
- An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00052052Phase 2
- A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving PrednisoneTerminatedNCT00052039Phase 3
- An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast CancerCompletedNCT00051779Phase 1
- Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic GastroparesisCompletedNCT00050882Phase 2
- Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis BCompletedNCT00048945Phase 3
- A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant PatientsCompletedNCT00048152Phase 3
- A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00048139Phase 2
- A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00048126Phase 2
- Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent AsthmaCompletedNCT00048022Phase 2
- Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled CorticosteroidsCompletedNCT00048009Phase 2
- Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal CancerCompletedNCT00047762Phase 1
- A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung CancerCompletedNCT00047736Phase 3
- A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047658Phase 2
- A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047645Phase 3
- Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal CancerTerminatedNCT00047632Phase 3
- Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC InfectionTerminatedNCT00043355Phase 2
- Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic FibrosisCompletedNCT00043342Phase 1/2
- Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant OsteopetrosisCompletedNCT00043329
- Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic FibrosisCompletedNCT00043316Phase 1/2
- Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or CirrhosisCompletedNCT00043303Phase 2
- T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV DrugsCompletedNCT00021554Phase 3
- Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by InjectionStatus unknownNCT00017784Phase 3
- Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal MeningitisCompletedNCT00012467Phase 2
- T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV DrugsCompletedNCT00008528Phase 3
- Paclitaxel and Capecitabine in Treating Women With Metastatic Breast CancerCompletedNCT00005649Phase 2